July 2025
1. ZHOU H, Luo H, Tang JY, Honer WG, et al
   Population-based study of long-term mortality risk associated with clozapine use among patients with schizophrenia.
   Br J Psychiatry. 2025 Jul 4:1-9. doi: 10.1192/bjp.2025.10312.
   

   >> Share

   
   June 2025
2. WILLIAMS R, Penington E, Gupta V, Quirk A, et al
   Critical components of 'Early Intervention in Psychosis': national retrospective cohort study.
   Br J Psychiatry. 2025 Jun 26:1-9. doi: 10.1192/bjp.2025.
   

   >> Share

   
   
3. REILLY TJ, Chesney E, Al-Diwani A, Jewell A, et al
   Identification of menstrual psychosis cases using electronic health records.
   Br J Psychiatry. 2025 Jun 23:1-3. doi: 10.1192/bjp.2025.
   

   >> Share

   
   
4. ANDREU-BERNABEU A, Gonzalez-Penas J, Mora A, Bernardo M, et al
   Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: results from EU-GEI study.
   Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
   

   >> Share

   
   
5. MUNOZ-CARACUEL M, Aleman-Morillo C, Garcia-San-Martin N, Garrido-Torres N, et al
   Predicting clinical and functional trajectories in individuals with first-episode psychosis by baseline deviations in grey matter volume.
   Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
   

   >> Share

   
   May 2025
6. WILKINSON H, Johns LC, Batchelor R, Lau-Zhu A, et al
   Cognitive behavioural therapy for sleep problems in psychosis: systematic review of effectiveness and acceptability.
   Br J Psychiatry. 2025 May 22:1-16. doi: 10.1192/bjp.2025.
   

   >> Share

   
   
7. O'HARE K, Lang U, Healy C, Kougianou I, et al
   Psychosis and bipolar disorder risk in child and adolescent mental health services in the UK: population cohort study.
   Br J Psychiatry. 2025 May 14:1-7. doi: 10.1192/bjp.2025.
   

   >> Share

   
   
8. MUSTONEN A, Taipale H, Denissoff A, Ellila V, et al
   Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.
   Br J Psychiatry. 2025 May 6:1-7. doi: 10.1192/bjp.2025.
   

   >> Share

   
   
9. SHAJU A, Mishra A, Mohapatra D, Srinivasan A, et al
   Efficacy and safety of cholinergic modulators in patients with schizophrenia: meta-analysis of randomised controlled trials.
   Br J Psychiatry. 2025 May 2:1-11. doi: 10.1192/bjp.2025.
   

   >> Share

   
   April 2025
10. MONCRIEFF J, Pillai E, Marston L, Lewis G, et al
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.
    Br J Psychiatry. 2025 Apr 14:1-7. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
11. LYMAN M, Fanshawe JB, Brewin J, Fanshawe TR, et al
    Introduction of point-of-care blood testing in early intervention in psychosis services: effects on physical health screening.
    Br J Psychiatry. 2025 Apr 11:1-6. doi: 10.1192/bjp.2025.
    

    >> Share

    
    March 2025
12. COWMAN M, Hodgekins J, Griffiths SL, Frawley E, et al
    Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes.
    Br J Psychiatry. 2025 Mar 26:1-8. doi: 10.1192/bjp.2025.
    

    >> Share

    
    
13. WHITING D, Glogowska M, Mallett S, Maughan D, et al
    Use of a violence risk prediction tool (Oxford Mental Illness and Violence) in early intervention in psychosis services: mixed methods study of acceptability, feasibility and clinical role.
    Br J Psychiatry. 2025 Mar 20:1-10. doi: 10.1192/bjp.2024.
    

    >> Share

    
    February 2025
14. LAGERBERG T, Lambe S, Paulino A, Yu R, et al
    Systematic review of risk factors for violence in psychosis: 10-year update.
    Br J Psychiatry. 2025;226:100-107.
    

    >> Share

    
    
15. ZANCHETA SB, de Alencar Quirino AH, Gomes SP, Nogueira GN, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study: commentary, Zancheta et al.
    Br J Psychiatry. 2025;226:114-115.
    

    >> Share

    
    January 2025
16. KANG S, Yang JS, Yun BH, Gelaye B, et al
    Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study.
    Br J Psychiatry. 2025 Jan 10:1-8. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
17. WANG F, Liu Z, Wang J, Li X, et al
    Aberrant controllability of functional connectome during working memory tasks in patients with schizophrenia and unaffected siblings.
    Br J Psychiatry. 2025 Jan 7:1-10. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
18. FERNANDEZ-EGEA E, McCutcheon RA
    Clozapine monitoring requirements: is it time for an update?
    Br J Psychiatry. 2025;226:1-3.
    

    >> Share

    
    December 2024
19. ZHOU J, Millier A, Aballea S, Francois C, et al
    Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.
    Br J Psychiatry. 2024 Dec 26:1-8. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
20. SMITH KA, Boyce N, Chevance A, Chiocchia V, et al
    Triangulating evidence from the GALENOS living systematic review on trace amine-associated receptor 1 (TAAR1) agonists in psychosis.
    Br J Psychiatry. 2024 Dec 23:1-9. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
21. NAUGHTON S, McGinty G, Duffy N, Marshall D, et al
    Intervening early across the lifespan: going beyond youth-focused psychosis care to meet the needs of women.
    Br J Psychiatry. 2024 Dec 4:1-3. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
22. YANG LH, Grivel MM, Blasco D, Girgis RR, et al
    Parsing stigma's relationship with the psychosocial functioning of youth identified as at clinical high risk for psychosis: evaluating whether symptom stigma or labelling stigma is stronger.
    Br J Psychiatry. 2024 Dec 4:1-9. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
23. CHESNEY E, Reilly TJ, Scott F, Slimani I, et al
    Psychosis associated with cannabis withdrawal: systematic review and case series.
    Br J Psychiatry. 2024 Dec 3:1-12. doi: 10.1192/bjp.2024.
    

    >> Share

    
    November 2024
24. GREENWOOD K, Jones C, Yaziji N, Healey A, et al
    The Early Youth Engagement (EYE-2) intervention in first-episode psychosis services: pragmatic cluster randomised controlled trial and cost-effectiveness evaluation.
    Br J Psychiatry. 2024 Nov 25:1-9. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
25. TREUR JL, Thijssen AB, Smit DJA, Tadros R, et al
    Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: genetic exploration of population samples.
    Br J Psychiatry. 2024 Nov 8:1-9. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
26. HALL J
    Schizophrenia - new treatments soon.
    Br J Psychiatry. 2024 Nov 8:1-2. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
27. TESLI N, Vaskinn A
    Violence and schizophrenia: let us take a deep breath and gain a meta-perspective.
    Br J Psychiatry. 2024;225:508-509.
    

    >> Share

    
    October 2024
28. YANG JS, Kang S, Kim K, Tsai AC, et al
    Breast cancer risk among women with schizophrenia and association with duration of antipsychotic use: population-based cohort study in South Korea.
    Br J Psychiatry. 2024 Oct 31:1-7. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
29. NICHOLLS D, Budd J, Nunn P, French P, et al
    Investigating inequalities in patient outcomes for first-episode psychosis.
    Br J Psychiatry. 2024 Oct 10:1-7. doi: 10.1192/bjp.2024.
    

    >> Share

    
    September 2024
30. JIANG Y, Chang X, Feng J
    Towards a unified theory of the aetiology of schizophrenia.
    Br J Psychiatry. 2024 Sep 23:1-3. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
31. FERNANDEZ-EGEA E, Flanagan RJ, Taylor D, Gaughran F, et al
    Mortality associated with clozapine: what is the evidence?
    Br J Psychiatry. 2024;225:357-359.
    

    >> Share

    
    August 2024
32. LIU R, Li D, Ma Y, Tang L, et al
    Air pollutants, genetic susceptibility and the risk of schizophrenia: large prospective study.
    Br J Psychiatry. 2024 Aug 9:1-9. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
33. KIKUCHI Y, Kurosawa M, Sakata M, Takahashi Y, et al
    Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals.
    Br J Psychiatry. 2024 Aug 6:1-7. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
34. FAROOQ S, Hattle M, Kingstone T, Ajnakina O, et al
    Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT).
    Br J Psychiatry. 2024 Aug 5:1-10. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
35. SHERGILL SS, Meshreky KM
    Towards a unified theory of the aetiology of schizophrenia: commentary, Shergill et al.
    Br J Psychiatry. 2024 Aug 5:1-2. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
36. KUMARI V
    Towards a unified theory of the aetiology of schizophrenia: commentary, Kumari.
    Br J Psychiatry. 2024;225:341-342.
    

    >> Share

    
    July 2024
37. HUANG ML, Wei LC
    Psychological framework to understand interpersonal violence by forensic patients with psychosis: commentary, Huang & Wei.
    Br J Psychiatry. 2024 Jul 31:1. doi: 10.1192/bjp.2024.
    

    >> Share

    
    May 2024
38. CHEN PH, Tsai SY, Chen PY, Pan CH, et al
    Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study.
    Br J Psychiatry. 2024 May 16:1-9. doi: 10.1192/bjp.2024.
    

    >> Share

    
    
39. FREEMAN D
    Developing psychological treatments for psychosis.
    Br J Psychiatry. 2024;224:147-149.
    

    >> Share

    
    
40. FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
    The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
    Br J Psychiatry. 2024;224:164-169.
    

    >> Share

    
    April 2024
41. QI R, Qureshi M, Gire N, Chaudhry IB, et al
    Ethnic density and first episode psychosis in the British Pakistani population: findings from the East Lancashire Early Intervention Service.
    Br J Psychiatry. 2024 Apr 18:1-6. doi: 10.1192/bjp.2024.
    

    >> Share

    
    March 2024
42. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium - CORRIGENDUM.
    Br J Psychiatry. 2024 Mar 18:1. doi: 10.1192/bjp.2024.
    

    >> Share

    
    February 2024
43. HASSIOTIS A, Noor M, Bebbington P, Ali A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence - CORRIGENDUM.
    Br J Psychiatry. 2024 Feb 13:1. doi: 10.1192/bjp.2024.
    

    >> Share

    
    January 2024
44. MCCUTCHEON RA, Cannon A, Parmer S, Howes OD, et al
    How to classify antipsychotics: time to ditch dichotomies?
    Br J Psychiatry. 2024;224:20-25.
    

    >> Share

    
    November 2023
45. SAHIN D, Kambeitz-Ilankovic L, Wood S, Dwyer D, et al
    Algorithmic fairness in precision psychiatry: analysis of prediction models in individuals at clinical high risk for psychosis.
    Br J Psychiatry. 2023 Nov 8:1-11. doi: 10.1192/bjp.2023.
    

    >> Share

    
    October 2023
46. LAMBE S, Cooper K, Fazel S, Freeman D, et al
    Psychological framework to understand interpersonal violence by forensic patients with psychosis.
    Br J Psychiatry. 2023 Oct 20:1-8. doi: 10.1192/bjp.2023.
    

    >> Share

    
    
47. KOHLER-FORSBERG O, Ge F, Hauksdottir A, Thordardottir EB, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study.
    Br J Psychiatry. 2023 Oct 18:1-7. doi: 10.1192/bjp.2023.
    

    >> Share

    
    
48. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Br J Psychiatry. 2023;223:485-492.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share